.png)
Agenzia Italiana del Farmaco
home
Highlights
-
02 Feb 2023
AIFA Notes
Monitoring consumption trends of AIFA Note 97
The updated report with the monitoring of consumption relating to medicines subject to AIFA Note 97 is available.
-
01 Feb 2023
Lists of Class A and Class H medicinal products
List of class A and H medicinal products at 15 August 2022
AIFA makes available, to healthcare professionals, a list of class A and H medicinal products dispensed by the National Health Service, sorted by active ingredient and trade name.
-
01 Feb 2023
Innovative medicinal products
Innovative medicines list: AIFA publishes Januar 2023 update
AIFA updates the list of medicines that, in the opinion of the Scientific and Technical Committee (CTS), meet the requirement of full or conditional therapeutic innovativeness.
-
27 Jan 2023
Monitoring Registers
Monitoring of antivirals for COVID-19: new report published
The Italian Medicines Agency (AIFA) has published the results of the monitoring of antivirals currently available for treating COVID-19.
News
02 Feb 2023
Access to medicinal products
Updated lists of allergens for specific immunotherapy and diagnosis published following the end of the transitional phase initiated with AIFA Decision DG 2130/2017
31 Jan 2023
Access to medicinal products
Direct communication with healthcare professionals on LYMPHOSEEK® (tilmanocept)
31 Jan 2023
Monitoring Registers
Hepatitis C: update of 30 January 2023 concerning enrolled patients
27 Jan 2023
Safety of medicinal products
EMA confirms measures to minimise risk of serious side effects with Janus kinase inhibitors for chronic inflammatory disorders
26 Jan 2023
Monitoring Registers
Monitoring of monoclonal antibodies for COVID-19: weekly report published
25 Jan 2023
Press releases
AIFA: Anna Rosa Marra appointed Interim Director General
COVID-19
Learn more
FarmaciLine
Questions regarding drug efficacy, safety and availability
TOLL-FREE NUMBER
Interactive OsMed - The use of medicines in Italy
An interactive consultation of data on the use of medicines in Italy in the general and regional population, described in terms of expenditure, volumes, typology
